Rena-Vite Tablets
Retirée du marché américain le 16 October 2023 (selon le DSLD)
Cypress Pharmaceutical, food supplement from the US market
Label withdrawn from the US market. Rena-Vite Tablets (Cypress Pharmaceutical), a food supplement au code-barres 360258160018, is described by its US market label, recorded on 16 June 2022. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. Doses of folates, niacine are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label, entered on 16 June 2022. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 10 mg a day according to the label (at most 1 serving a day), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Cypress Pharmaceutical
- Barcode
- 360258160018
- Form
- Tablet
- One serving
- 1 tablet
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Dicalcium Phosphate, Microcrystalline Cellulose, Croscarmellose Sodium, Stearic Acid, Hypromellose, Magnesium Stearate, Talc, FD&C Red #40 Lake, Polyethylene Glycol, Mineral Oil, FD&C Yellow #6 Lake, Titanium Dioxide
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin C | Vitamin | 60 mg |
| Vitamin B1 | Vitamin | 1.5 mg |
| Vitamin B2 | Vitamin | 1.7 mg |
| Niacinamide | Vitamin | 20 mg |
| Vitamin B6 | Vitamin | 10 mg |
| Folate | Vitamin | 1,333 µg DFE (dietary folate equivalent) |
| Folic Acid | Vitamin | 800 µg |
| Vitamin B12 | Vitamin | 6 µg |
| Biotin | Vitamin | 300 µg |
| Pantothenic Acid | Vitamin | 10 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Rena-Vite
Entered into DSLD on 25 September 2013. Retirée du marché américain le 16 October 2023 (selon le DSLD).- Active ingredient removed : Folate (1,333 mcg DFE)
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : Cypress Pharmaceutical